Stocks and Investing Stocks and Investing
Mon, July 12, 2021
Sat, July 10, 2021
Fri, July 9, 2021
Thu, July 8, 2021
Wed, July 7, 2021
Tue, July 6, 2021
Mon, July 5, 2021
Fri, July 2, 2021

Anupam Rama Maintained (APLS) at Buy with Increased Target to $101 on, Jul 2nd, 2021


Published on 2024-10-27 17:06:55 - WOPRAI, Anupam Rama
  Print publication without navigation


Anupam Rama of JP Morgan, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Buy with Increased Target from $91 to $101 on, Jul 2nd, 2021.

Anupam has made no other calls on APLS in the last 4 months.



There are 4 other peers that have a rating on APLS. Out of the 4 peers that are also analyzing APLS, 1 agrees with Anupam's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tiago Fauth of "Credit Suisse" Maintained at Hold with Increased Target to $39 on, Thursday, April 29th, 2021


These are the ratings of the 3 analyists that currently disagree with Anupam


  • Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $85 on, Monday, June 28th, 2021
  • Eliana Merle of "UBS" Initiated at Strong Buy and Held Target at $82 on, Friday, May 21st, 2021
  • Madhu Kumar of "Goldman Sachs" Initiated at Strong Buy and Held Target at $130 on, Friday, April 16th, 2021